Skip navigation |

Research & Audit

Audit

Yorkshire white roseProspective clinical audit is expected on each leg of the rotation, with the aim of presentation at both national meetings and at the annual Yorkshire Urology Audit Group (YUAG) meeting held in November each year.

The region has a long history of producing relevant audit projects and the regional audit group meeting has been in place for the last 21 years. Details of the audit presentations given to the 2011 meeting are shown below:

MORNING SESSION - PODIUM PRESENTATIONS
Chair: Mr J Hall
Judges: Mr P Koenig, Mr J Cartledge

1.

Comparison study of OnabotulinumtoxinA 300U and 200U in patient with detrusor overactivity
Mangera A, Malki M, Reid S, Inman R, Chapple CR.
AWARDED THIRD PLACE IN MORNING SESSION

2.

The documentation of urethral catheterisation. Are we getting it right?
Nandhra S, Matson J, Clapham E, Urwin G, Wilson R.
OVERALL BEST PRESENTATION - AWARDED THE GORDON BRYDEN MEDAL

3.

Impact on histopathological reporting with different collection protocols for TRUS biopsy of the prostate
Harris F, Fragkopoulou C, Dabbagh V, Nandwani GM, Addla SK.

4.

Incidence of urinary tract infections following flexible cystoscopy. A prospective study
Baldo O, Khan H, Koenig P, Shaikh N.

5.

Scrotal exploration: a hit and miss affair
Mohee A, Bretsztajn L, Eardley I.

6.

30 day re-admissions: cause for concern?
Finney SM, Chan KH, Stower MJ, Hanchanale V, Wilson JR, Urwin G.

7.

A review of referrals for suspected testicular malignancy: the two-week wait dilemma continues
Harikrishnan J, Sharaf A, Jain S.

8.

Audit of the early learning curve of laparoscopic partial nephrectomy
Forster JA, Biyani CS (video clip shown below)

9.

Does following NICE guidelines for active surveillance of low-risk prostate cancer result in only short-term freedom from radical intervention?
Phillips R, Smith NJ, Sundaram SK, Weston PMT, Chahal R.

10.

Do prostate cancer nomograms give accurate information when applied to Yorkshire patients?
Forster JA, Turo R, Prescott S, Paul AB, Cross WR.
AWARDED FIRST PLACE IN MORNING SESSION

11.

Muscle invasion and disease-specific mortality in patients with low-risk bladder cancer: time to change follow-up?
Linton KD, Thomas F, Rubin N, Rosario DJ, Catto JW.
AWARDED SECOND PLACE IN MORNING SESSION
12. An assessment of the complications of open radical cystectomy with and without naso-gastric tubes - is a naso-gastric tube still routinely required?
Patterson J, Malki M, Haynes M, Rosario DJ, Catto J.

13.

Improved outcomes following radical cystectomy for bladder cancer at a higher volume centre: is increased cystectomy workload not the determining factor?
Smith NJ, Douglas D, Sundaram SK, Weston PMT, Cahal R.

14.

Day-case Gyrus TURP - is it feasible?
Raymond I, Lloyd SM, Lloyd SN.

Go to the top of the pageTop

BAUS UPDATE
Mr John Anderson, BAUS President-elect

GUEST LECTURE
The Urologist's Stethoscope
(sponsored by GE Healthcare)
Mr William T Lawrence

GUEST LECTURE
Changes in urology since 1988
Mr MJ Stower

AFTERNOON SESSION - PODIUM PRESENTATIONS
Chair: Mr MJ Stower
Judges: Mr L Chowoo, Mr R Wilson

15.

Erectile dysfunction management in Leeds
Mohee A, Khan A, Storey A, Eardley I.

16.

Is it cost effective to allow urological trainees to perform laparoscopic nephrectomy?
Kimuli M, Spurgeon T, Cartledge J.

17.

Laparoscopic versus open partial nephrectomy: a tertiary centre's experience
Youssef FR, Haynes MD, Cuthina PE, SmithDJ, Oakley NE (video clip shown below).

18.

Does the management of the distal ureter at laparoscopic nephroureterectomy affect early surgical outcome?
Khafagy R, Harikrishnan J, Nunn A, Cartledge J, Jain S.

19.

Audit of 14 years experience of laparoscopic adrenalectomy using the Uro-Clavien-Dindo classification of complications
Forster JA, Sandhu R, Browning AJ,Biyani CS.
AWARDED THIRD PLACE IN AFTERNOON SESSION

20.

FRAX assessment of men treated with androgen deprivation therapy for prostate cancer
Turo R, Cross W.
AWARDED FIRST PLACE IN AFTERNOON SESSION

21.

Is transurethral resection of the prostate safe and effective in men aged over 80 years?
Bhardwaj R, Kimuli M, Jain (presented by Forster L).

22.

An audit comparing the quality of TURBT in a dedicated and non-dedicated TURBT list
Yeo L, Jain S.
AWARDED SECOND PLACE IN AFTERNOON SESSION

23.

Single-centre experience of continent and orthotopic urinary diversion following radical cystectomy
Smith NJ, Lazarowicz HP, Sundaram SK, Weston PMT, Harrison SCW, Chahal R.

24.

The long-term outcome of high-risk non-muscle invasive bladder cancer
Thomas F, Rubin N, Goepel J, Rosario DJ, Abbod MF, Catto JWF.

25.

Recent trends in morbidity and mortality following percutaneous nephrostomy insertion
Gill JD, Burton D, Scullion D, Mawhinney R, Singh P, Davies A-M, Kimber R.

26.

MiniArcâ„¢ sling for female stress urinary incontinence (SUI) - a district general hospital experience
Hanchanale VS, Finney S, Urwin G.

27.

Evaluation of the registrar on-call activity in a tertiary care urology unit
Rajpal S, Venugopal S, Patterson J, Rosario DJ.
GE Healthcare

We would like to acknowledge the extreme generosity and support offered to this event by GE Healthcare

 

Thanks are also offered to the following companies for their ongoing support and sponsorship:

Astellas, Bayer Healthcare, Boston Scientific, Cambridge Laboratories, Cook Medical, Ethicon, Femcare-Nikomed, GSK, Hitatchi, Hollister, Ipsen, Karl Storz, Lilly, Pfizer, Sanofi Aventis, SEP, Takeda

Go to the top of the pageTop